Jon Smith looks back on some words of wisdom from Warren Buffett about how and where to invest as the market keeps rallying.

GSK respiratory/immunology research and development global head Kaivan Khavandi stated: “Working with Relation enables us to ...

Inequalities in childhood vaccination are widening in England, with uptake rates of five key vaccines consistently lower in young children living in areas of higher deprivation from 2019 to 2023, ...

Relation Therapeutics Ltd. has delivered the first commercial validation of its combined wet lab/in silico platform for homing in on disease-related genes in the thick of the genome, signing two ...

The U.S. FDA has greenlit the first steps of Uniqure NV’s accelerated approval pathway for gene therapy AMT-130 to treat Huntington’s disease. The agency said data from the ongoing phase I/II studies ...

As part of the deal, GSK will pay Relation $45 million in upfront payments, which includes an equity investment of $15 million.

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Big pharma company GSK and UK AI-biotech Relation Therapeutics have entered into two strategic collaborations to identify and ...

UK-based biotech Relation Therapeutics today announced two multi-program strategic collaborations with pharma major GSK. The ...

FOR IMMEDIATE RELEASERelation announces two strategic collaborations with GSK to advance therapeutics for fibrotic diseases and ...

Relation announced two multi-program strategic collaborations with GSK (GSK). The collaborations will focus on the identification and ...

ACI-24.060 has received Fast Track designation from the U.S. FDA for the treatment of AD. The Company previously reported positive interim safety, tolerability, and immunogenicity from the AD cohorts ...